Detalhe da pesquisa
1.
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Pharmacogenet Genomics
; 31(1): 1-9, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649577
2.
Principled multi-omic analysis reveals gene regulatory mechanisms of phenotype variation.
Genome Res
; 28(8): 1207-1216, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29898900
3.
Identification of pathways associated with chemosensitivity through network embedding.
PLoS Comput Biol
; 15(3): e1006864, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30893303
4.
Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation.
EMBO Rep
; 19(3)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29335246
5.
SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.
PLoS Genet
; 13(10): e1007031, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968398
6.
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
Breast Cancer Res
; 21(1): 47, 2019 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30944027
7.
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer.
Pharmacogenet Genomics
; 29(8): 183-191, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31211741
8.
Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines.
Hum Mol Genet
; 25(21): 4819-4834, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28173075
9.
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.
Pharmacogenet Genomics
; 28(6): 147-152, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29768301
10.
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.
BMC Cancer
; 17(1): 709, 2017 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29096610
11.
Preclinical-to-clinical Anti-cancer Drug Response Prediction and Biomarker Identification Using TINDL.
Genomics Proteomics Bioinformatics
; 21(3): 535-550, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36775056
12.
Testis- specific Y-encoded- like protein 1 and cholesterol metabolism: Regulation of CYP1B1 expression through Wnt signaling.
Front Pharmacol
; 13: 1047318, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36518674
13.
Anastrozole Regulates Fatty Acid Synthase in Breast Cancer.
Mol Cancer Ther
; 21(1): 206-216, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667110
14.
Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer.
Clin Pharmacol Ther
; 110(4): 1038-1049, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048027
15.
CDC25B partners with PP2A to induce AMPK activation and tumor suppression in triple negative breast cancer.
NAR Cancer
; 2(4): zcaa039, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385163
16.
Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.
JCI Insight
; 5(16)2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32701512
17.
Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α.
Clin Cancer Res
; 26(12): 2986-2996, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32098767
18.
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2.
Clin Pharmacol Ther
; 106(1): 219-227, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30648747
19.
Considerations for automated machine learning in clinical metabolic profiling: Altered homocysteine plasma concentration associated with metformin exposure.
Pac Symp Biocomput
; 23: 460-471, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218905
20.
Machine Learning Helps Identify New Drug Mechanisms in Triple-Negative Breast Cancer.
IEEE Trans Nanobioscience
; 17(3): 251-259, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29994716